Phase II Study of Erlotinib Plus Temozolomide During and After Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma

PURPOSE: This open-label, prospective, single-arm, phase II study combined erlotinib with radiation therapy (XRT) and temozolomide to treat glioblastoma multiforme (GBM) and gliosarcoma. The objectives were to determine efficacy of this treatment as measured by survival and to explore the relationsh...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Prados, Michael D., Chang, Susan M., Butowski, Nicholas, DeBoer, Rebecca, Parvataneni, Rupa, Carliner, Hannah, Kabuubi, Paul, Ayers-Ringler, Jennifer, Rabbitt, Jane, Page, Margaretta, Fedoroff, Anne, Sneed, Penny K., Berger, Mitchel S., McDermott, Michael W., Parsa, Andrew T., Vandenberg, Scott, James, C. David, Lamborn, Kathleen R., Stokoe, David, Haas-Kogan, Daphne A.
Format: Artigo
Jezik:Inglês
Izdano: American Society of Clinical Oncology 2009
Teme:
Original Reports
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2645859/
https://ncbi.nlm.nih.gov/pubmed/19075262
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2008.18.9639
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki